Skip to content

Comparison Between Conventional Angiocatheter Versus New Anchoring Device (KARAHOC) Used for Paracentesis

Comparison of Success Rate and Complication Between Conventional Angiocatheter Versus New Anchoring Device (KARAHOC) Used for Paracentesis in Cirrhotic Patients With Ascites

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05578573
Enrollment
80
Registered
2022-10-13
Start date
2022-01-17
Completion date
2022-12-31
Last updated
2022-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ascites Hepatic

Keywords

paracentesis, cirrhosis, ascites

Brief summary

Comparison of success rate and complication between conventional angiocatheter versus new anchoring device (KARAHOC) used for paracentesis in cirrhotic patients with ascites.

Detailed description

This study is a multi-center, prospective, interventional study, in which subjects who meet the selection criteria are registered at each institution during the study period from the date of research approval. Regardless of the order, paracentesis using KARAHOC and conventional angiocatheter will be performed once in all patients. The criteria for successful paracentesis is set as 3L or more of ascites drainage. During paracentesis, albumin will be infused in all patients. Heart rate and blood pressure will be measured before the procedure and right after the completion of drainage, and 30 minutes later. The incidence of complications will be compared between two methods. In addition, patient and operator satisfaction will be investigated using a visual analogue scale.

Interventions

DEVICEKARAHOC device

After leaving a mark on the part where the puncture is to be performed using a pen, sterilization dressing are performed, local anesthesia is performed aseptic then ascites paracentesis by KARAHOC device.

After leaving a mark on the part where the puncture is to be performed using a pen, sterilization dressing are performed, local anesthesia is performed aseptic then ascites paracentesis by angiocatheter

Sponsors

Sang Gyune Kim
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

multi-center, prospective, interventional study

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult over the age of 19 * Patients with pathological or clinical diagnosis of liver cirrhosis * Patients with Grade 2 or higher grade of ascites as a complication due to portal hypertension * Patients requiring periodic paracentesis * Patients consent to this study

Exclusion criteria

(If at least one of the following conditions apply) * Patients with ascites due to peritoneal metastasis due to malignant tumor * Patients with high bleeding risk (PT INR\>3, PLT\<30,000/mm3) difficult to perform ascites puncture * Patients with hepatic encephalopathy or hepatorenal syndrome(HRS) * Patients with severe cardiovascular disease, lung disease, or DIC * Patients refusing paracentesis * Patients who can control ascites using diuretics * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Comparison of success rate between conventional angiocatheter versus KARAHOC device used for paracentesisthrough study completion, an average of 1 yearThe criterion for successful paracentesis is defined as drainage of 3L or more at an initial attempt.

Secondary

MeasureTime frameDescription
comparison of complication ratethrough study completion, an average of 1 yearthe frequency of bleeding, hypotension, acute kidney injury, infection
operator satisfaction for each procedurethrough study completion, an average of 1 yearmeasure the amount of satisfaction using visual analogue scales distributed from 1 to 10, higher score means better outcome
patient satisfaction for each procedurethrough study completion, an average of 1 yearmeasure the amount of satisfaction using visual analogue scales distributed from 1 to 10, higher score means better outcome
Number of Participants with repeated paracentesisthrough study completion, an average of 1 yearWhether to do paracentesis again due to initial failure or catheter dislocation

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 5, 2026